Granules India Ltd.

₹569.55

Granules India Ltd.

Add Alert
Add Watchlist

₹569.55

₹569.55

-0.55 (-0.1%) - 18 Oct 2025 04:25 PM

About Company

Granules India Limited is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs). The company’s product-focused, vertically integrated business model has created a leadership position in several generic drugs. It has a strong presence in ‘first line of defence’ products, including Paracetamol, Ibuprofen, Guaifenesin and Metformin.

Market Cap. ₹ 13,821 Cr.
52 Week - High/Low ₹ 721/422
P/E Ratio 46.80
P/B Ratio 4.06
Enterprise Value ₹ 13,799 Cr.
ROE % 9.85
RSI Value 68.56
EMA 50 524.37
EMA 200 511.45
Market Cap. ₹ 13,821 Cr.
52 Week - High/Low ₹ 721/422
P/E Ratio 28.81
P/B Ratio 3.72
Enterprise Value ₹ 13,691 Cr.
ROE % 14.52
RSI Value 68.56
EMA 50 524.37
EMA 200 511.45

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.